Your session is about to expire
← Back to Search
Platelet-Rich Fibrin Treatment for Gum Recession
Study Summary
This trial tests a new treatment for gum recession that may be as effective as the current method.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I cannot have gum surgery due to health reasons.My teeth are very loose or have severe gum damage.I have a history of blood disorders like abnormal clotting.I am an adult with healthy gums and no systemic health issues.I have serious health issues like obesity, uncontrolled diabetes, or weak immunity.I have deep gum recession needing surgery to cover the root.I have ongoing gum damage from brushing my teeth too hard.I have severe tooth misalignment or noticeable tooth eruption.I haven't had any gum grafting procedures in the past year.I am not allergic to Polysorbate 20, Cefoxitin, Lincomycin, polymyxin B, or Vancomycin.I have untreated gum disease or infections at the surgery area.I currently smoke more than 10 cigarettes a day or use tobacco/vape regularly.I have cancer that hasn't been treated at the surgery area.
- Group 1: Connective Tissue Graft
- Group 2: Allogenic Dermal Matrix with Platelet-Rich Fibrin
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What objectives does this research endeavor seek to fulfill?
"This trial aims to achieve complete root coverage (CRC) and will be evaluated at 6 months. Secondary objectives include measuring soft tissue volume changes over time with dental ultrasonography, assessing and quantifying alterations in soft tissue blood flow using ultrasound technology, and gauging patient-reported esthetics with a Visual Analogue Scale ranging from 0 to 10."
Are there any unfilled vacancies in this research endeavor?
"Unfortunately, the clinical trial listed on clinicialtrials.gov is no longer accepting applicants; it was initially published on April 29th 2023 and last updated a few weeks later. However, there are 33 other trials currently recruiting patients that may be of interest as an alternative option."
Share this study with friends
Copy Link
Messenger